Leap Therapeutics
LPTX
LPTX
72 hedge funds and large institutions have $32.7M invested in Leap Therapeutics in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.51% less ownership
Funds ownership: 4.26% → 3.75% (-0.51%)
24% less capital invested
Capital invested by funds: $43.2M → $32.7M (-$10.6M)
Holders
72
Holding in Top 10
1
Calls
$255K
Puts
$27K
Top Buyers
| 1 | +$726K | |
| 2 | +$626K | |
| 3 | +$432K | |
| 4 |
Jane Street
New York
|
+$115K |
| 5 |
KCFA
Key Client Fiduciary Advisors
Fairfield,
New Jersey
|
+$53.9K |
Top Sellers
| 1 | -$619K | |
| 2 | -$575K | |
| 3 | -$422K | |
| 4 |
Two Sigma Advisers
New York
|
-$300K |
| 5 |
Renaissance Technologies
New York
|
-$202K |